Physician profile
Uma Duvvuri
NPI 1891756573
$5,685.53
in general payments reported to CMS, 2019-2025
16 companies · $235 in 2025
The $235 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,204 · 2020: $774 · 2021: $155 · 2022: $482 · 2023: $736 · 2024: $1,099 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,069.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,473.13 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,282.39 | 2019-2024 | Jardiance |
| Glaxosmithkline, LLC. | $929.86 | 2019-2024 | Arexvy, Bexsero |
| Amarin Pharma, INC. | $317.11 | 2019-2023 | |
| Exact Sciences Corporation | $307.50 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $305.29 | 2019-2025 | |
| Lilly USA, LLC | $245.60 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $225.36 | 2020-2024 | Verquvo, Gardasil 9, Gardasil |
| Genentech USA, INC. | $198.56 | 2019-2020 | |
| Novo Nordisk INC | $137.74 | 2019-2020 | |
| Abbott Laboratories | $90.00 | 2019 | |
| Gilead Sciences, INC. | $88.64 | 2019-2020 | |
| Amgen INC. | $25.52 | 2019-2024 | Repatha, Otezla |
| Intuitive Surgical, INC. | $24.86 | 2020 | |
| Mannkind Corporation | $20.83 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uma Duvvuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.